DASGIP Parallel Bioreactor Systems for Unparalleled Results
DASGIP develops and manufactures technologically superior parallel bioreactor systems designed for the lab-scale cultivation of bacterial, mammalian and human cells.
Since January 2012 DASGIP is an Eppendorf company.
Process engineers, researchers and product development specialists who work with biotechnology processes rely on DASGIP parallel bioreactor systems to drive their projects forward, thus benefiting from increased cell and media productivity, reproducible and scalable results, and shortened innovation cycles.
Benchtop Bioreactors - Causing a Stir
We discuss the factors to consider when selecting a bioreactor.
-
08.05.2012
Controlled Cultivation of Stem Cells -
04.04.2012
DASGIP Presentation at Interphex 2012 -
14.03.2012
Effectively upscaling bioprocesses
References
More and more commercial enterprises and research institutes in the fields of biotechnology, pharmaceuticals, chemicals and cosmetics, as well as food and animal feed, are benefiting from DASGIP technology. By now, nine of the ten worldwide leading pharmaceutical companies are among our customer base.